30
Participants
Start Date
October 31, 2003
Primary Completion Date
December 31, 2009
Study Completion Date
April 30, 2010
Taxotere
X mg/m2, IV (in the vein) on day 1 of each 28 day cycle. Number of Cycles: until progression or unacceptable toxicity develops.
5-FU
800 mg/m2, CIV (conti.in the vein) on day 1\~4 of each 28 day cycle. Number of Cycles: until progression or unacceptable toxicity develops.
Briplatin
15 mg/m2, IV (in the vein) on day 1\~4 of each 28 day cycle. Number of Cycles: until progression or unacceptable toxicity develops.
・ Hokkaido University Hospital (Hokkaido University Graduate School of Medicine / School of Medicine), Sapporo
Hokkaido University Hospital
OTHER
Hokkaido Gastrointestinal Cancer Study Group
OTHER